Feed SSMXY
SS

Sysmex Corporation

SSMXY · OTC

$11.82 +0.08% (+$0.01)
1M -3.77%
Market Cap ¥1.17T
P/E Ratio 29.07x
Div. Yield 1.65%
ROE 8.15%

Bulios Fair Price

$10.34

12.5% downside

Current Price

$11.82

Undervalued Fair Value Overvalued

According to Bulios Fair Price, SSMXY is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Moderate
6/9
Valuation
64 /100
Fair
P/E 29.07x
EV/EBITDA 9.81x
P/S 2.19x
Growth
69 /100
Growing
EPS growth 7.04%
Rev. growth 11.82%
FCF growth 15.56%
Profitability
71 /100
Strong
Gross margin 50.96%
Net margin 7.54%
Op. margin 13.12%
Quality
45 /100
Average
ROIC 7.82%
ROE 8.15%
ROA 5.42%
Debt
100 /100
Low
Debt/Equity 0.25x
Current ratio 3.40x
Int. coverage 14.94x
Stability
100 /100
Stable
Beta 0.69x
Rev. volatility 1.41%
EPS volatility 2.72%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about SSMXY
Online

About the company

Sysmex Corporation is a Japanese technology company specializing in the manufacture of diagnostic devices and systems for medical purposes. Founded in 1968 and headquartered in Kobe, Japan, Sysmex is known primarily for its advanced technologies in automated blood testing and laboratory diagnostic equipment, which are used in hospitals and laboratories worldwide.

Sector

Healthcare

Industry

Medical - Specialties

CEO

Hisashi Ietsugu

Employees

10,861

Headquarters

Kobe

Upcoming events

29 SEP

Ex-Dividend

Ex-dividend date

8d
04 NOV

Earnings

Upcoming earnings report

44d
02 DEC

Dividend Payment

Payment date

72d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.